Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee E Schechter

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Analytical Chemistry|July 16, 2004
Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approachPurnima Khandelwal, Chad E Beyer, Qian Lin, et al.
Journal of Neuroscience Methods|February 6, 2004
Nanoprobe NMR spectroscopy and in vivo microdialysis: new analytical methods to study brain neurochemistryPurnima Khandelwal, Chad E Beyer, Qian Lin, et al.
Brain Research|April 25, 2008
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatmentsDarrick T Balu, Brian A Hoshaw, Jessica E Malberg, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligandsRonald Bernotas, Steven Lenicek, Schuyler Antane, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Innovative approaches for the development of antidepressant drugs: current and future strategiesLee E Schechter, Robert H Ring, Chad E Beyer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2007
Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effectsJessica E Malberg, Brian Platt, Stacey J Sukoff Rizzo, et al.
Brain Research|March 7, 2008
Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxineZia Rahman, Robert H Ring, Kimberly Young, et al.
Brain Research|September 9, 2004
Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivoChad E Beyer, Afshin Ghavami, Qian Lin, et al.
Journal of Neurochemistry|June 30, 2006
WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native systemXavier Z Khawaja, Deborah L Smith, Stanley P Nawoschik, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Novel aryloxy-8-azabicyclo[3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinityAdam M Gilbert, Thomas Coleman, Jason Kodah, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Analytical Chemistry|July 16, 2004
Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approachPurnima Khandelwal, Chad E Beyer, Qian Lin, et al.
Journal of Neuroscience Methods|February 6, 2004
Nanoprobe NMR spectroscopy and in vivo microdialysis: new analytical methods to study brain neurochemistryPurnima Khandelwal, Chad E Beyer, Qian Lin, et al.
Brain Research|April 25, 2008
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatmentsDarrick T Balu, Brian A Hoshaw, Jessica E Malberg, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligandsRonald Bernotas, Steven Lenicek, Schuyler Antane, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 21, 2006
Innovative approaches for the development of antidepressant drugs: current and future strategiesLee E Schechter, Robert H Ring, Chad E Beyer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 8, 2007
Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effectsJessica E Malberg, Brian Platt, Stacey J Sukoff Rizzo, et al.
Brain Research|March 7, 2008
Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxineZia Rahman, Robert H Ring, Kimberly Young, et al.
Brain Research|September 9, 2004
Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivoChad E Beyer, Afshin Ghavami, Qian Lin, et al.
Journal of Neurochemistry|June 30, 2006
WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native systemXavier Z Khawaja, Deborah L Smith, Stanley P Nawoschik, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Novel aryloxy-8-azabicyclo[3.2.1]oct-3-enes with 5-HT transporter and 5-HT1A affinityAdam M Gilbert, Thomas Coleman, Jason Kodah, et al.
Pageof 7